262% share price rise for Perth biotech after IPO

23/09/2019 - 12:35

Bookmark

Upgrade your subscription to use this feature.

Singapore and Perth-based biotech company Osteopore has begun life on the ASX today with a sharp share price surge, following a $5.25 million initial public offering.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options